Assessment of the optimal timing for projected dose evaluation in head and neck cancer patients treated with helical tomotherapy

Read full text Summarise with VIRAT
Authors: Suwapim Chanlaor, Jayanton Patumanond, Chawalit Lakdee, Boriphat Kadman
Cited by: 0
References: 17

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Background: This study aimed to determine the optimal time point at which the projected dose most accurately corresponds to the accumulated dose in head and neck cancer patients treated with helical tomotherapy. Dose metric differences between the International Commission on Radiation Units and Measurements Report 83 (ICRU83) (D50%) and Radiation Therapy Oncology Group (RTOG) (D95%) protocols were also evaluated for the planning target volume and critical organs, including the parotid glands, spinal cord, and brainstem. Materials and methods: This methods-oriented study analyzed data from 61 head and neck cancer patients treated with helical tomotherapy. It compared projected and accumulated doses across the treatment course, assessing dose discrepancies at fractions 1, 5, 10, 15, 20, 25, and 30. A ±3% threshold was defined as the acceptable deviation for both target volumes and critical organs. Results: Among the 61 patients analyzed, 70.5% had T3-T4 tumors and 68.8% were planned using the ICRU83 protocol. No deviations exceeding ±3% were observed in planning target volume dose 70 Gy (PTV70) (D50%) under ICRU83 protocol, whereas 35.0% of RTOG protocol (D95%) cases showed dose underestimation during fractions 1, 5, and 10. Deviations exceeding ±3% occurred most frequently in the left parotid gland (up to 75.4% of cases), followed by the right parotid gland, spinal cord and brainstem, particularly during early fractions. Conclusions: Projected dose proved to be a reliable metric for evaluating dose consistency, with D50% under ICRU83 protocol stable from early treatment and D95% under RTOG protocol consistent after fraction 15. However, variations in projected doses for organs at risk emphasize the need for cautious interpretation and individualized adaptive planning.

Fields of Study & Subjects

Advanced Radiotherapy Techniques Radiation Therapy and Dosimetry Radiation Dose and Imaging

Publication details

Journal / source
Reports of Practical Oncology & Radiotherapy
Volume
31
Issue
2
Pages
186–193
Publication date
25 March 2026
Language
EN